Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antimullerian hormone

被引：73
|
作者：
Toner, James P. [1 ]
Seifer, David B. [2 ,3 ]
机构：
[1] Atlanta Ctr Reprod Med, Atlanta, GA 30328 USA
[2] Maimonides Hosp, Brooklyn, NY 11219 USA
[3] NYU, Dept Obstet & Gynecol, Sch Med, New York, NY 10016 USA
来源：
FERTILITY AND STERILITY | 2013年 / 99卷 / 07期
关键词：
Ovarian reserve; AMH; MIS; FSH; IVF; ART; ovarian response; ovarian biomarker; egg supply; ovarian hyperstimulation; ANTI-MULLERIAN HORMONE; ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; LUTEINIZED GRANULOSA-CELLS; SERUM INHIBIN-B; OOCYTE ASPIRATION; MENSTRUAL-CYCLE; WOMEN; AMH; AGE;
D O I：
10.1016/j.fertnstert.2013.03.001
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Antimullerian hormone is the most informative serum marker of ovarian reserve currently available and should be considered an important part of any contemporary reproductive medicine practice. It is both more convenient and informative than basal FSH and can be assessed at any point in the cycle. It is the most useful serum method of determining ovarian reserve, which guides pretreatment counseling, choice of infertility treatment, and avoidance of ovarian hyperstimulation. The future role of basal FSH testing is in doubt. ((c) 2013 by American Society for Reproductive Medicine.)
引用
收藏
页码：1825 / 1830
页数：6
相关论文
共 50 条
  • [21] A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist
    Garmes, Heraldo Mendes
    Grassiotto, Oswaldo Rocha
    Fernandes, Yvens Barbosa
    Queiroz, Luciano de Souza
    Vassalo, Jose
    de Oliveira, Daniel Minutti
    Benetti-Pinto, Cristina Laguna
    FERTILITY AND STERILITY, 2012, 97 (01) : 231 - 234
  • [22] Basal estradiol:follicle-stimulating hormone ratio predicts ovarian response to gonadotropic stimulation in patients with normal ovulation
    Abd-El-Maeboud, KHI
    ADVANCES IN THERAPY, 1999, 16 (04) : 164 - 174
  • [23] An Ovarian Reserve Assessment Model Based on Anti-Mullerian Hormone Levels, Follicle-Stimulating Hormone Levels, and Age: Retrospective Cohort Study
    Xu, Huiyu
    Shi, Li
    Feng, Guoshuang
    Xiao, Zhen
    Chen, Lixue
    Li, Rong
    Qiao, Jie
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (09)
  • [24] Negative impact of high doses of follicle-stimulating hormone during superovulation on the ovulatory follicle function in small ovarian reserve dairy heifers
    Karl, Kaitlin R.
    Jimenez-Krassel, Fermin
    Gibbings, Emily
    Ireland, Janet L. H.
    Clark, Zaramasina L.
    Tempelman, Robert J.
    Latham, Keith E.
    Ireland, James J.
    BIOLOGY OF REPRODUCTION, 2021, 104 (03) : 695 - 705
  • [25] Assessment of ovarian reserve with anti-Mullerian hormone: a comparison of the predictive value of anti-Mullerian hormone, follicle-stimulating hormone, inhibin B, and age - Discussion
    Schnorr, John A.
    Dr Riggs
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (02)
  • [26] Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles
    La Marca, A.
    Papaleo, E.
    Grisendi, V.
    Argento, C.
    Giulini, S.
    Volpe, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (10) : 1171 - 1179
  • [27] Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone
    Seifer, DB
    Scott, RT
    Bergh, PA
    Arbogast, LK
    Friedman, CI
    Mack, CK
    Danforth, DR
    FERTILITY AND STERILITY, 1999, 72 (01) : 63 - 65
  • [28] Follicle-stimulating hormone receptor genotype and its influence on the results of ovarian stimulation using corifollitropin alfa
    Hortal Foronda, M.
    Cascales, A.
    Ortiz, J. A.
    Lledo, B.
    Guerrero, J.
    Bernabeu, A.
    Bernabeu, R.
    HUMAN REPRODUCTION, 2022, 37 : I459 - I460
  • [29] WHEN ANTIMULLERIAN AND FOLLICLE STIMULATING HORMONE OFFER A DISCREPANT PROGNOSIS OF OVARIAN RESERVE, IN VITRO FERTILIZATION OUTCOMES ARE WORSE THAN WHEN BOTH VALUES PREDICT POOR OVARIAN RESERVE.
    Harris, I. D.
    Wang, S.
    Roth, L.
    Alvero, R.
    McShane, P.
    Schlaff, W. D.
    FERTILITY AND STERILITY, 2010, 94 (04) : S26 - S26
  • [30] Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection
    Arce, Joan-Carles
    Andersen, Anders Nyboe
    Fernandez-Sanchez, Manuel
    Visnova, Hana
    Bosch, Ernesto
    Garcia-Velasco, Juan Antonio
    Barri, Pedro
    de Sutter, Petra
    Klein, Bjarke M.
    Fauser, Bart C. J. M.
    FERTILITY AND STERILITY, 2014, 102 (06) : 1633 - U456
12345